position,0.517471
WallachBeth Capital,0.250937
buy,0.266772
earnings results,-0.311385
Asset Management LLC,0.344109
lipoprotein lipase deficiency,-0.68643
stock,0.107563
hold rating,0.266772
Equities research analysts,0.208552
InvestorPlace Broker Center,0.555736
orphan metabolic disease,-0.817079
MarketBeat Ratings reports,-0.220137
1-year high,-0.641995
high fees,-0.735674
research report,0.308374
hedge funds,-0.245274
Perceptive Advisors LLC,0.517471
Uniqure NV,-0.303997
personal trading style,0.598412
Roth Capital,0.348808
target price,-0.0109074
buy rating,0.266772
UNIQURE B.V.,-0.470139
Perceptive Advisors,0.592501
shares,0.441542
acquired diseases,-0.470139
gene therapy,-0.470139
average target price,-0.323893
company,0.426137
stock broker,0.245696
consensus rating,0.428045
Eventide Asset Management,0.344109
quarter,0.509704
